Variant report
Variant | nsv946512 |
---|---|
Chromosome Location | chr1:175013171-175019073 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:610)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr1:175015281-175015313 | GM13976 | blood: | n/a | n/a |
2 | CUX1 | chr1:175016175-175016205 | K562 | blood: | n/a | n/a |
3 | GATA3 | chr1:175017866-175018320 | SH-SY5Y | brain: | n/a | n/a |
4 | MYC | chr1:175014402-175014570 | MCF-7 | breast: | n/a | n/a |
5 | MYC | chr1:175014457-175014486 | MCF-7 | breast: | n/a | n/a |
6 | POLR2A | chr1:175013257-175013275 | MCF-7 | breast: | n/a | n/a |
7 | POLR2A | chr1:175013838-175013959 | MCF-7 | breast: | n/a | n/a |
8 | POLR2A | chr1:175014739-175014902 | GM12878 | blood: | n/a | n/a |
9 | POLR2A | chr1:175013211-175013223 | A549 | lung: | n/a | n/a |
10 | POLR2A | chr1:175013900-175013951 | MCF-7 | breast: | n/a | n/a |
11 | POLR2A | chr1:175013276-175013320 | MCF-7 | breast: | n/a | n/a |
12 | POLR2A | chr1:175013228-175013345 | A549 | lung: | n/a | n/a |
13 | POLR2A | chr1:175014740-175014871 | GM12878 | blood: | n/a | n/a |
14 | POLR2A | chr1:175014373-175014470 | MCF-7 | breast: | n/a | n/a |
15 | REST | chr1:175017351-175017518 | H1-hESC | embryonic stem cell: | n/a | n/a |
16 | TEAD4 | chr1:175012912-175013304 | H1-hESC | embryonic stem cell: | n/a | n/a |
17 | TEAD4 | chr1:175012935-175013310 | H1-hESC | embryonic stem cell: | n/a | n/a |
18 | UBTF | chr1:175013949-175013992 | K562 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:175014375-175014425 | SAEC | small airway: | n/a |
2 | chr1:175014924-175014974 | CMK | blood: | n/a |
3 | chr1:175014375-175014425 | HepG2 | liver: | n/a |
4 | chr1:175015908-175015958 | HMEC | breast: | n/a |
5 | chr1:175014375-175014425 | HCM | heart: | n/a |
6 | chr1:175014805-175014855 | U87 | brain: | n/a |
7 | chr1:175015908-175015958 | HRE | kidney: | n/a |
8 | chr1:175014924-175014974 | HPAEpiC | pulmonary alveolar: | n/a |
9 | chr1:175014037-175014087 | IMR90 | lung: | fetal |
10 | chr1:175014805-175014855 | HCPEpiC | choroid plexus: | n/a |
11 | chr1:175013154-175013204 | PFSK-1 | brain: | n/a |
12 | chr1:175013352-175013402 | PrEC | prostate: | n/a |
13 | chr1:175014611-175014661 | PFSK-1 | brain: | n/a |
14 | chr1:175014060-175014110 | ECC-1 | luminal epithelium: | n/a |
15 | chr1:175013352-175013402 | GM12878 | blood: | n/a |
16 | chr1:175014375-175014425 | AG04449 | skin: | fetal |
17 | chr1:175014924-175014974 | SK-N-SH | brain: | n/a |
18 | chr1:175013920-175013970 | NHBE | bronchial: | n/a |
19 | chr1:175014611-175014661 | H1-hESC | embryonic stem cell: | embryo |
20 | chr1:175013154-175013204 | HEEpiC | esophagus: | n/a |
21 | chr1:175014805-175014855 | HCF | heart: | n/a |
22 | chr1:175014611-175014661 | GM12878 | blood: | n/a |
23 | chr1:175015908-175015958 | NB4 | blood: | n/a |
24 | chr1:175013352-175013402 | ECC-1 | luminal epithelium: | n/a |
25 | chr1:175014924-175014974 | HRPEpiC | eye: | n/a |
26 | chr1:175014037-175014087 | HCM | heart: | n/a |
27 | chr1:175014805-175014855 | GM12878 | blood: | n/a |
28 | chr1:175013352-175013402 | BJ | skin: | n/a |
29 | chr1:175014375-175014425 | AG04450 | lung: | fetal |
30 | chr1:175014060-175014110 | IMR90 | lung: | fetal |
31 | chr1:175014060-175014110 | Hela-S3 | cervix: | n/a |
32 | chr1:175014924-175014974 | NT2-D1 | testis: | n/a |
33 | chr1:175015908-175015958 | NHBE | bronchial: | n/a |
34 | chr1:175015908-175015958 | SK-N-SH | brain: | n/a |
35 | chr1:175014037-175014087 | NB4 | blood: | n/a |
36 | chr1:175014924-175014974 | Caco-2 | colon: | n/a |
37 | chr1:175013154-175013204 | SKMC | muscle: | n/a |
38 | chr1:175014375-175014425 | A549 | lung: | n/a |
39 | chr1:175013352-175013402 | HepG2 | liver: | n/a |
40 | chr1:175015908-175015958 | ProgFib | skin: | n/a |
41 | chr1:175014611-175014661 | Hepatocyte | liver: | n/a |
42 | chr1:175014924-175014974 | H1-hESC | embryonic stem cell: | embryo |
43 | chr1:175014611-175014661 | HUVEC | blood vessel: | n/a |
44 | chr1:175014375-175014425 | ProgFib | skin: | n/a |
45 | chr1:175014060-175014110 | ovcar-3 | ovarian: | n/a |
46 | chr1:175014611-175014661 | ECC-1 | luminal epithelium: | n/a |
47 | chr1:175014611-175014661 | Hela-S3 | cervix: | n/a |
48 | chr1:175014060-175014110 | ProgFib | skin: | n/a |
49 | chr1:175014805-175014855 | NB4 | blood: | n/a |
50 | chr1:175015908-175015958 | GM12891 | blood: | n/a |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:175018453..175021258-chr1:175048643..175051325,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
SDCCAG3P2 | TF binding region |
SDCCAG3P2 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs538696663 | chr1:175013201-175013202 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114312541 | chr1:175013213-175013214 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572612244 | chr1:175013220-175013221 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541727063 | chr1:175013232-175013233 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs71645226 | chr1:175013233-175013234 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561298075 | chr1:175013250-175013251 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs575005477 | chr1:175013287-175013288 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs144047871 | chr1:175013340-175013341 | Enhancers Bivalent Enhancer Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs374754973 | chr1:175013422-175013423 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555694010 | chr1:175013430-175013431 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562620112 | chr1:175013508-175013509 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531437282 | chr1:175013528-175013529 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551355059 | chr1:175013531-175013532 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs189421494 | chr1:175013536-175013537 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6661580 | chr1:175013543-175013544 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs181474862 | chr1:175013577-175013578 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs376960347 | chr1:175013584-175013585 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547696164 | chr1:175013595-175013596 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs74128553 | chr1:175013628-175013629 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs146472784 | chr1:175013631-175013632 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113525244 | chr1:175013661-175013662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549862052 | chr1:175013714-175013715 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs569770365 | chr1:175013740-175013741 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs185319705 | chr1:175013750-175013751 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572464939 | chr1:175013770-175013771 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558489448 | chr1:175013780-175013781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541486920 | chr1:175013783-175013784 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs189823762 | chr1:175013850-175013851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs181087358 | chr1:175013871-175013872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564549801 | chr1:175013874-175013875 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543987375 | chr1:175013876-175013877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs575212662 | chr1:175013915-175013916 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576170904 | chr1:175013932-175013933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs3737935 | chr1:175013936-175013937 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs564703768 | chr1:175013944-175013945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs527313626 | chr1:175013948-175013949 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540956143 | chr1:175013976-175013977 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs561284624 | chr1:175013987-175013988 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs149730439 | chr1:175014000-175014001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs543631545 | chr1:175014012-175014013 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549526294 | chr1:175014055-175014056 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569532862 | chr1:175014085-175014086 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs532443396 | chr1:175014092-175014093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552668971 | chr1:175014115-175014116 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs565919415 | chr1:175014116-175014117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535058506 | chr1:175014160-175014161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554669266 | chr1:175014164-175014165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs568696077 | chr1:175014177-175014178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs537754568 | chr1:175014242-175014243 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7355181 | chr1:175014250-175014251 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Rett syndrome | 21593744 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Breast cancer | 21509527 | CNVD |
Glioblastoma multiforme | 17369134 | CNVD |
Cancer | 17440070 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21611746 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Autism | 22241247 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:174993200-175013800 | Weak transcription | Spleen | Spleen |
2 | chr1:175012000-175014200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr1:175012600-175013400 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
4 | chr1:175013000-175013400 | Bivalent Enhancer | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr1:175013000-175013400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
6 | chr1:175013000-175013400 | Bivalent Enhancer | Fetal Muscle Leg | muscle |
7 | chr1:175013000-175013400 | Enhancers | Fetal Stomach | stomach |
8 | chr1:175013000-175013600 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr1:175013000-175013600 | Enhancers | Fetal Muscle Trunk | muscle |
10 | chr1:175013000-175013800 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr1:175013000-175013800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr1:175013000-175013800 | Enhancers | Fetal Lung | lung |
13 | chr1:175013000-175014000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
14 | chr1:175013000-175014000 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr1:175013200-175013800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
16 | chr1:175013200-175013800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr1:175013400-175013800 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
18 | chr1:175013800-175014400 | Enhancers | Spleen | Spleen |